Latest Regulatory Approval News

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Orthocell has secured Health Canada approval for its nerve repair product Remplir™, adding the US$75 million Canadian market and expanding its total addressable market to US$1.8 billion. The company plans to appoint local distributors and expects first sales in H2 2025.

Actinogen Medical advances its XanaMIA phase 2b/3 Alzheimer’s trial with faster patient enrolment and expands clinical sites, while achieving a pivotal FDA meeting outcome for its depression program. The company maintains a strong cash position, supporting ongoing development and commercialization efforts.

Opthea Limited has discontinued its wet AMD development program following Phase III trial failures, slashing its workforce by 65% amid ongoing financial uncertainty and negotiations with investors.

Biome Australia is set to expand its Activated Probiotics range with two new products targeting vaginal health and perinatal care, tapping into a booming women’s health supplements market.

Anson Resources reports a successful pilot of Direct Lithium Extraction technology at its Green River project with 98% lithium recovery, while securing approvals for a 24-hole drilling program at its Yellow Cat Uranium-Vanadium project.

Arafura Rare Earths has marked a pivotal quarter with a A$200 million cornerstone equity commitment for its Nolans Project, alongside binding offtake agreements securing two-thirds of its NdPr oxide target amid rising rare earth demand and geopolitical tensions.

Icon Energy Limited has received a Notice of Proposed Grant for Petroleum Lease PL-1144 in the Cooper Basin, marking a significant step toward resource development. Meanwhile, the company secured a $300,000 unsecured loan under revised terms, though its shares remain suspended pending native title negotiations and ASX approval.

Battery Minerals Ltd has launched comprehensive geophysical and geochemical programs at its El Aguila Gold-Silver Project in Argentina, setting the stage for maiden drilling in Q3 2025 pending approvals.

Renergen Limited reported a near doubling of revenue driven by increased LNG production and prices, yet its loss after tax more than doubled due to commissioning costs and higher depreciation. The company has begun commercial liquid helium sales and is navigating funding challenges and ongoing litigation.

Sun Silver Limited has announced a substantial upgrade to its Maverick Springs Project resource, now totalling nearly 480 million ounces silver equivalent, alongside key leadership appointments and the launch of its 2025 drilling campaign.

Titanium Sands Limited has secured the Terms of Reference for the Environmental Impact Assessment of its Mannar Heavy Mineral Project, marking a pivotal regulatory milestone. The company is also progressing tenure retention applications amid plans for further capital raising.